These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
298 related articles for article (PubMed ID: 23445811)
1. Extracellular Hsp90 (eHsp90) as the actual target in clinical trials: intentionally or unintentionally. Li W; Tsen F; Sahu D; Bhatia A; Chen M; Multhoff G; Woodley DT Int Rev Cell Mol Biol; 2013; 303():203-35. PubMed ID: 23445811 [TBL] [Abstract][Full Text] [Related]
2. Detection and Analysis of Extracellular Hsp90 (eHsp90). Cortes S; Baker-Williams AJ; Mollapour M; Bourboulia D Methods Mol Biol; 2018; 1709():321-329. PubMed ID: 29177669 [TBL] [Abstract][Full Text] [Related]
3. Emerging Roles of Extracellular Hsp90 in Cancer. Wong DS; Jay DG Adv Cancer Res; 2016; 129():141-63. PubMed ID: 26916004 [TBL] [Abstract][Full Text] [Related]
4. Extracellular Heat Shock Protein-90 (eHsp90): Everything You Need to Know. Jay D; Luo Y; Li W Biomolecules; 2022 Jun; 12(7):. PubMed ID: 35883467 [TBL] [Abstract][Full Text] [Related]
5. Secreted Hsp90 is a novel regulator of the epithelial to mesenchymal transition (EMT) in prostate cancer. Hance MW; Dole K; Gopal U; Bohonowych JE; Jezierska-Drutel A; Neumann CA; Liu H; Garraway IP; Isaacs JS J Biol Chem; 2012 Nov; 287(45):37732-44. PubMed ID: 22989880 [TBL] [Abstract][Full Text] [Related]
6. A Fluorescent Hsp90 Probe Demonstrates the Unique Association between Extracellular Hsp90 and Malignancy in Vivo. Crowe LB; Hughes PF; Alcorta DA; Osada T; Smith AP; Totzke J; Loiselle DR; Lutz ID; Gargesha M; Roy D; Roques J; Darr D; Lyerly HK; Spector NL; Haystead TAJ ACS Chem Biol; 2017 Apr; 12(4):1047-1055. PubMed ID: 28103010 [TBL] [Abstract][Full Text] [Related]
18. The double-edged sword: conserved functions of extracellular hsp90 in wound healing and cancer. Hance MW; Nolan KD; Isaacs JS Cancers (Basel); 2014 May; 6(2):1065-97. PubMed ID: 24805867 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of cancer invasion and metastasis by targeting the molecular chaperone heat-shock protein 90. Koga F; Kihara K; Neckers L Anticancer Res; 2009 Mar; 29(3):797-807. PubMed ID: 19414312 [TBL] [Abstract][Full Text] [Related]
20. Altered Hsp90 function in cancer: a unique therapeutic opportunity. Bagatell R; Whitesell L Mol Cancer Ther; 2004 Aug; 3(8):1021-30. PubMed ID: 15299085 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]